Skip to main content
. 2022 Jun 7;20:257. doi: 10.1186/s12967-022-03471-y

Fig. 2.

Fig. 2

Single-agent checkpoint inhibitor stuides in ovarian cancer. Levinson et al. ASCO Ed. Book (2019)